WA
TMDX icon

Whipplewood Advisors’s Transmedics TMDX Stock Holding History

Whipplewood Advisors’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4
Closed -$536 – 1074
2025
Q2 		$536 Sell
4
-97
-96% -$10.7K ﹤0.01% 1113
2025
Q1 		$471 Buy
101
+80
+381% +$5.5K ﹤0.01% 1132
2024
Q4 		$1.31K Buy
+21
New +$1.96K ﹤0.01% 966

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Whipplewood Advisors's TMDX Position: Q3 2025 in Review

Whipplewood Advisors sold out of Transmedics (TMDX) in Q3 2025, closing a stake of 4 shares — an estimated $536 sold.

Whipplewood Advisors first reported a position in TMDX in Q4 2024 and held it in 3 quarters. The position peaked at $1.31K in Q4 2024. 388 funds tracked by Wall St. Rank hold TMDX as of Q3 2025.

  • Whipplewood Advisors reported no remaining Transmedics position as of Q3 2025 after selling out during the quarter.
  • Whipplewood Advisors sold 4 Transmedics shares in Q3 2025, an estimated $536.
  • Whipplewood Advisors first reported a position in Transmedics in Q4 2024 and held it in 3 quarters.
  • Whipplewood Advisors's Transmedics position peaked at $1.31K in Q4 2024.
  • 388 funds tracked by Wall St. Rank held Transmedics as of Q3 2025.

Based on Whipplewood Advisors's 13F filing for Q3 2025, filed 6 Nov 2025.